GESSEL advises Urteste S.A. on a public placement of new issue shares and on transfer of its shares
20.03.2023 Case studies Capital Markets
GESSEL advises Urteste S.A. on a public placement of new issue shares and on transfer of its shares from the NewConnect alternative trading system to the main floor of the Warsaw Stock Exchange. The prospectus was approved by the Polish Financial Supervision Authority on 16 March 2023, with Dom Maklerski Banku Ochrony Środowiska S.A. serving as the issue coordinator.
Our lawyers drew up a comprehensive set of corporate and issue documentation, conducted due diligence of the issuer company, represented it in proceedings for approval of the prospectus and, generally, provided Urteste and Dom Maklerski BOŚ with legal support in all aspects of the project.
This is the second public placement in which we had the pleasure of advising Urteste; we already worked with the company in 2021, when it first floated its shares on the NewConnect market.
Urteste S.A. is a Gdansk-based biotech which is perfecting methods for detecting early-stage cancers on the basis of urine samples. At present, the company has viable test prototypes for ten of the fifteen defined diagnostic objectives.
We take this opportunity to thank Urteste S.A., Dom Maklerski BOŚ, Marcin Hauffa B-Think, and Kamil Majcher for a fruitful cooperation!
Lawyers involved in the project
You may also like
15.03.2024
We advised Gaz-System on its purchase of Gas Storage Poland from Orlen
We provided legal support to Gaz-System S.A. in execution with Orlen S.A., on 14 March 2024, of a conditional share purchase agreement for a 100% stake in Gas Storage Po...
07.03.2024
The President of the Office of Competition and Consumer Protection (UOKIK) has given further approval for the concentration of our long-standing customer ANWIM S.A.
On March 4, 2024, the President of the Office of Competition and Consumer Protection (UOKiK) issued another approval for the concentration of our long-term client Anwim ...